|
|
|
|
Science Sparks @ ACTREC
|
 29 June 2026 |
Vol. No. 15 ; Issue No.741 |
|
|
Publications
|
|
1. Mehrotra M, Chakraborty S, Saldanha E, Joshi D, Dhadve A, Sakpal A, Chandrani P, Maheshwari A, Menon S, Ghosh J, Gupta S, Ray P (2026). Alpelisib enhances cisplatin mediated cytotoxicity in non-mutated, PIK3CA-dependent high-grade serous ovarian cancer. Journal of Ovarian Research.
2. Murthy V, Maitre P, Priya S, Dhingra S, Dhanawat A, Shah M, Bhattacharya K, Adepu A, Singh P, Phurailatpam R, Patil D, Noronha V, Prabhash K, Misra A, Arora A, Pal M, Prakash G, Menon S, Joshi A (2026). Reduced length of ADT and ARTA with XRT in high-risk prostate cancer: A randomised controlled trial,
Clinical Oncology.
3. Shinde A, Ahire S, Ingle A (2026). Diagnosis of naturally occurring Klebsiella pneumoniae in rodent colonies using conventional, PCR and DNA sequencing method: A Case Report. Journal of Laboratory Animal Science. 9(2): 18-24.
Thesis
Priyanka Arun Jadhav. 2025. Biophysical Studies of Experimental Carcinogenesis in Hamster Buccal Pouch Model: Deciphering Sequential Changes (LIFE09201904010) (Guide: Dr. C Murali Krishna)
|
|
|
|
|
|
|
Video of the Week
|
|
| Emerging Bispecific Antibody Treatment Strategies in Advanced Colorectal Cancer
|
|
| |
|
|
| |
|
|
|
|
Do You Know?
In ,1989 US FDA approved Carboplatin, a derivative of cisplatin, for chemotherapy.
|
|
|
|
Cancer News
|
| |
|
A common vitamin could help fight one of the deadliest brain cancers.
|
|
Sciencedaily, 22/06/2026
|
|
A clinical trial is exploring whether high doses of vitamin B3 could give patients with glioblastoma a better chance against the aggressive brain cancer. Scientists found that niacin may help revive immune cells that tumors shut down, allowing them to attack cancer more effectively...
|
| |
|
|
|
|
| |
|
|
|
Lipid nanoparticles enhance immune response against lung cancer.
|
|
News-Medical.Net 25/06/2026
|
|
The approach enhances a process called immunogenic cell death, or ICD, a form of cancer cell death that alerts the immune system to the presence of tumors. Researchers increasingly view ICD as a promising way to help the body recognize, attack and remember cancer cells...
|
|
|
|
|
|
|
|
|
2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
